Network meta-analysis of 103 RCTs (20,941 participants) in acute bipolar depression: in low-risk-of-bias sensitivity analysis, lamotrigine 50 or 200 mg/day, quetiapine XR 150/300 mg/day and lumateperone 42 mg/day beat placebo on symptoms; none did on response or acceptability.
Meta-analysisn = 20,941
Fornaro et al. Efficacy, acceptability, and related outcomes of pharmacological interventions for acute bipolar depression: A systematic review and dose-related network meta-analysis across different age groups